262 related articles for article (PubMed ID: 15913749)
1. The antinociceptive effect of zolpidem and zopiclone in mice.
Pick CG; Chernes Y; Rigai T; Rice KC; Schreiber S
Pharmacol Biochem Behav; 2005 Jul; 81(3):417-23. PubMed ID: 15913749
[TBL] [Abstract][Full Text] [Related]
2. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
[TBL] [Abstract][Full Text] [Related]
4. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
7. Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol.
Rojas-Corrales MO; Berrocoso E; Micó JA
Eur J Pharmacol; 2005 Mar; 511(1):21-6. PubMed ID: 15777775
[TBL] [Abstract][Full Text] [Related]
8. The antinociceptive effects and pharmacological properties of JM-1232(-): a novel isoindoline derivative.
Chiba S; Nishiyama T; Yamada Y
Anesth Analg; 2009 Mar; 108(3):1008-14. PubMed ID: 19224817
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
Yue CQ; Ye J; Li CL; Li RT; Sun Q
Pharmacol Biochem Behav; 2007 Apr; 86(4):643-50. PubMed ID: 17379285
[TBL] [Abstract][Full Text] [Related]
10. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
11. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent antagonism and potentiation of nitrous oxide antinociception by naloxone in mice.
Quock RM; Curtis BA; Reynolds BJ; Mueller JL
J Pharmacol Exp Ther; 1993 Oct; 267(1):117-22. PubMed ID: 8229738
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
[TBL] [Abstract][Full Text] [Related]
14. The antinociceptive properties of reboxetine in acute pain.
Schreiber S; Frishtick R; Volis I; Rubovitch V; Pick CG; Weizman R
Eur Neuropsychopharmacol; 2009 Oct; 19(10):735-9. PubMed ID: 19577903
[TBL] [Abstract][Full Text] [Related]
15. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the alpha2A-adrenoceptor gene.
Ozdoğan UK; Lähdesmäki J; Scheinin M
Eur J Pharmacol; 2006 Jan; 529(1-3):105-13. PubMed ID: 16325800
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive and hypnotic properties of Celastrus orbiculatus.
Park HJ; Cha DS; Jeon H
J Ethnopharmacol; 2011 Oct; 137(3):1240-4. PubMed ID: 21821110
[TBL] [Abstract][Full Text] [Related]
17. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms.
Schreiber S; Rigai T; Katz Y; Pick CG
Brain Res Bull; 2002 Sep; 58(6):601-5. PubMed ID: 12372565
[TBL] [Abstract][Full Text] [Related]
19. Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
Mendes TC; Raimundo JM; Nascimento-Junior NM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
Pharmacol Biochem Behav; 2009 Nov; 94(1):70-4. PubMed ID: 19635495
[TBL] [Abstract][Full Text] [Related]
20. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
Hesse LM; von Moltke LL; Greenblatt DJ
CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
